BUZZ-Australia's Lumos Diagnostics set for best day in 8-1/2 months on US contract win

Reuters09-25

** Shares of Lumos Diagnostics Holdings rise as much as 23.4% to A$0.042, set for best day since Jan. 11 - if current gains hold

** Medical equipment manufacturer announces placement of its respiratory test FebriDx on the U.S. MediGroup national contract

** Says MediGroup is single largest non-acute care group purchasing organisaton, which oversees equipment procurement for healthcare providers

** FebriDx evaluates respiratory infection in a patient during emergency care

** Shares hit highest level since Sept 9

** LDX down 44.5% YTD, including day's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment